Although both vaccines are generally well tolerated w an acceptable safety profile 6 cases of inflammatory neurologic events Guillain Barr syndrome GBS acute disseminated encephalomyelitis ADEM and others were reported after RSV vaccination in clinical tr

By rray, 31 October, 2023
Exclude Patient Type Detail Header
No
Detail Type
Text
Patient Type Detail Header (Long)
Although both vaccines are generally well-tolerated w/ an acceptable safety profile, 6 cases of inflammatory neurologic events (Guillain-Barré syndrome (GBS), acute disseminated encephalomyelitis (ADEM), and others) were reported after RSV vaccination in clinical trials. Until more evidence becomes available, target RSV vaccination to those at highest risk for severe RSV dz: